This painting was hiding in plain sight at GlaxoSmithKline until an inventory revealed that it is part of a series painted by N. C. Wyeth in 1929. Until this discovery in 2012, eleven of the sixteen paintings were unaccounted for. GlaxoSmithKline generously donated the work to the Museum. Today, on Wyeth’s birthday, we are proud to have this painting and celebrate his incredible talent.

If you happen to know where the other ten are, let us know.

The Trial of the Bow,” 1929, by N. C. Wyeth

DEVELOPING: GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3 billion to settle the largest case of healthcare fraud in U.S. history, according to court filings and prosecutors.

The settlement includes $1 billion in criminal fines and $2 billion in civil fines in connection with the sale of the drug company’s Paxil, Wellbutrin and Avandia products.

READ MORE: GlaxoSmithKline settles fraud charges for $3 billion 

Malaria scientist celebrates success after 24 years, what now?

(Reuters) - For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world’s first malaria vaccine, Tuesday, October 18, 2011 goes down as a fabulous day.


"There were many ups and downs, and moments over the years when we thought ‘Can we do it? Should we continue? Or is it really just too tough?," he told Reuters, as data showing the success of his RTS,S vaccine were unveiled at an international conference on malaria.

Now all we need to do is to figure out how to prevent those 390 000 babies he’ll be helping to save from malaria each year from starving to death, succumbing to one of the other nasties, or being butchered in one of the pointless conflicts that blight this beautiful Dark Continent.

As we keep more people alive in more places for longer, we place our planet under ever more pressure and increase our own obligation to be more gentle, caring and thoughful in the way we live our own lives. 

Apologies for the return to this topic, but it is a massive one for me.  

We congratulate ourselves on solving the easy problems (relatively speaking) like reducing infant mortality and eradicating disease only to abandon those we have “saved” to lives of unthinkable wretchedness.

GlaxoSmithKline will be making obscene profits on the back of this for years while you and I pay to subsidise the vaccinations and to feed those who have been saved .  

How about a licensing precondition that 50% of their real profits be used to manage the on-the-ground consequences of an exponentially increased global population?

Malaria vaccine

Brand spankin new. It will only work in about 50% of children that receive it, but that will “potentially translate into tens of millions if cases of malaria in children averted annually”. Also, it won’t be available in the US. But still, hurray!

Successful trials of malaria vaccine could lead to approval by 2015

Late-stage clinical trials of what could become the world’s first anti-malaria vaccine successfully protected a significant percentage of infants and young children in sub-Saharan Africa from contracting malaria up to 18 months after vaccination, leading drug company GlaxoSmithKline to announce that it will apply for regulatory approval of the vaccine next year, the company said Tuesday.

GSK teamed up with research centers in seven African countries and the PATH Malaria Vaccine Initiative (MVI), a non-profit that’s funded by the Bill and Melinda Gates Foundation, to test its malaria vaccine, called RTS,S.

Read more

Photo: Justin Sullivan/Getty Images

Big Pharma Kills Other People's Children

It’s ok.  The big bad pharmacy companies go to other countries and kill their babies so you don’t have to worry yourself about what is going on with the world and this great system called Capitalism.

GlaxoSmithKline Fined Over Illegal Vaccine Experiments Killing 14 Babies - BlackListedNews.comBy Anthony Gucciardi Vaccine and drug giant GlaxoSmithKline (GSK) has been fined 400,000 pesos (around the equivalent of $93,000) by an Argentinian judge for killing 14 babies during illegal lab vaccine trials that were conducted between 2007 and 2008.

via Blacklistednews

Original Article

paxil hell

today is the day. i have decided i am no longer going to take the poison prescribed to me to treat my severe social anxiety. in 5 months i have gained an obscene amount of weight and feel worse than i ever did before. so fuck you ms. doctor lady. i hear theres awful withdrawals. bring. it. on.

Drugmaker GlaxoSmithKline, already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the British company said on Sunday.

The latest controversy centers on claims that the company hired government-employed physicians and pharmacists in Iraq as paid sales representatives to improperly boost use of its products.

"We are investigating allegations of improper conduct in our Iraq business. We have zero tolerance for unethical or illegal behavior," a company spokesman said.

Continue reading

Check out The Denver Post investigative report: “Drug firms have used dangerous tactics to drive sales to treat kids.” It concludes:

"Nothing is going to change significantly until a few top people go to jail," [lawyer Stephen] Sheller said. "There is too much money to gain by marketing the drugs illegally."


For decades, some of this nation’s largest corporations have courted thousands of conservative lawmakers at annual conferences of the American Legislative Exchange Council (ALEC). Along with the food, drink, and dancing, member attendance to the conference comes with access to hundreds of industry-drafted bills that their hosts would like to see passed by state legislatures and Congress.

And, like any good courtship, ALEC’s member corporations and associations were generous to their state-lawmaker partners when it came time to get serious about the relationship.

How serious?

An examination of campaign donations made by ALEC corporate members dating back to the 1990 election cycle shows that they contributed $12.2 million to state-level candidates who were ALEC members, with 98.4 percent of that money going to incumbent and winning candidates, many of whom could vote on proposed legislation. Additional analysis reveals that $11.9 million of the $12.2 million went to Republicans. Click here to download the database.

Over the seven (10 for some states) election cycles covered in a donor-data analysis by the National Institute on Money in State Politics, ALEC corporate members contributed $516.2 million to state-level politics: $202.1 million to state-level candidates, $228.3 million to high-dollar ballot-measure campaigns, and $85.8 million to state political party committees.

Half a billion dollars. A serious relationship. It seems ALEC is not afraid of commitment.

Companies with an interest in today’s high-stakes health-care debate are at the top of the list of ALEC members who gave generously to state political campaigns.

TABLE 1: Health-care Industry ALEC Members: Contributions to State Political Campaigns                                                ALEC MemberAmount Contributed to State PoliticsPHRMA$76.4 millionPfizer$21.2 millionGlaxoSmithKline$15.5 millionJohnson & Johnson$14.6 millionMerck & Co$14.5 million

ALEC members with a stake in environmental-regulation debates also donated generously.

TABLE 2: Oil Industry ALEC Members: Contributions to State Political CampaignsALEC MemberAmount Donated to State PoliticsChevron Corp$52.2 millionConocoPhillips$8.4 millionBP NorthAmerica$6.5 millionExxonMobile$5.3 millionKoch Industries$2.5 million

Telecommunications policy? AT&T gave $39 million; Verizon, $13.2 million; Comcast, $8.6 million; Qwest Communications, $3.3 million; SprintNextel, $2.5 million.

The bottom line is, all sides of corporate America met willing partners at ALEC conferences, sat side by side with elected lawmakers to draft industry-friendly legislation, and helped those candidates win elections to ensure that their legislation had the best possible chance of passage.

The top recipients of donations from ALEC corporate members reads like a who’s who of state politics: ALEC “alumnus” Gov. Rick Perry of Texas received more than $2 million from 268 donations made by just 50 ALEC corporate members, far and away the most of any candidate in the decade of data analyzed.

Other top recipients include long-time Texas State Representative Tom Craddick, who accepted $878,110 from 198 donations made by 46 donors; Indiana Gov. Mitch Daniels with $659,737 from 197 donations made by 51 donors; long-time California State Representative Mike Villines with $347,796 from 214 donations from 84 donors; and Illinois State Senator Kirk Dillard with $320,289 from 357 donations from 59 donors.

The Institute’s analysis of the $12.2 million in ALEC corporate-member donations to state-level candidates who are ALEC members reveals:

  1. Candidates in Texas received more than $3.8 million, or 31 percent of the total, well above the $922,761 received by candidates in California, the next-highest recipient state.
  2. State representatives received more than $4.5 in ALEC-member contributions and state senators more than $3.4 million, all from a total of just over 10,000 checks.
  3. Gubernatorial candidates received more than $4 million, from just 1,050 checks written by ALEC members.
  4. Incumbent candidates—those already elected once to public office and making decisions about public policy—received more than $10.8 million of the total, or 88 percent.
  5. Republicans received more than $11.9 million of the total (96.7 percent) that ALEC members gave in more than 12,000 donations. Democrats received $392,136 from 571 donations.

At the interface of disciplines

The Chief Executive of GlaxoSmithKline, Andrew Witty, said tonight in BBC2 that they have designed their Research and Development divisions so that clusters of people working in similar projects work in close proximity. Their experience is that innovation happens at the interface of disciplines.

I believe that this happens because of the challenge that comes from those seeing the activity in one discipline and challenging it in the context of their own.

Innovation adds value, so one question we all need to ask is whether this kind of collaboration will lead to real value being added quickly to businesses. 

Building a collaborative team of challenging peers in different disciplines is a, perhaps the, winning strategy for entrepreneurial businesses. Are you doing it?

GlaxoSmithKline was socked with $3 billion in fines by US authorities over charges it marketed drugs for unauthorized uses, held back safety data, and cheated the government’s Medicaid program.


GSK, one of the world’s largest health care and pharmaceuticals companies, pleaded guilty on three counts and agreed to the fines in what the department called the largest health care fraud settlement in US history.

The British drugmaker admitted to charges that it had promoted antidepressants Paxil and Wellbutrin for uses not approved for by US regulators, including treatment of children and adolescents.

The company also conceded charges that it held back data and made unsupported safety claims over its diabetes drug Avandia.


And separately, GSK is being fined $300 million to settle charges it underpaid rebates it owed to the US Medicaid program.